Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ODC1 | P11926 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL223905 | 0.94 | DNM1 (0.36) | LMNADNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL734326 | 0.92 | DNM1 (0.39) | LMNADNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL28858270 | 0.87 | LMNA (0.31) | LMNA | |
| SCHEMBL10782479 | 0.87 | ODC1 (0.35) | ODC1 | |
| SCHEMBL189973 | 0.87 | ODC1 (0.35) | LMNAODC1 | |
| SCHEMBL29623660 | 0.86 | LMNA (0.44) | LMNADNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL29988559 | 0.86 | LMNA (0.44) | LMNADNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL3623133 | 0.86 | LMNA (0.39) | LMNADNM1MEN1KMT2AALDH1A1 | |
| SCHEMBL30483344 | 0.85 | ODC1 (0.33) | ODC1 | |
| SCHEMBL28977725 | 0.85 | LMNA (0.33) | LMNAODC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700896-A | Mute material for trunk casters and preparation method thereof | 东莞市励骏高分子材料有限公司 | 2024-03-15 | — | — | CN | claimed |
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | HENKEL AG & CO KGAA (DE) | 2026-03-26 | — | — | US | disclosed |
| EP-4269462-B1 | TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A THERMOPLASTIC POLYURETHANE | HENKEL AG & CO KGAA (DE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4663713-A1 | BONDED STRUCTURE COMPRISING AN THERMALLY DEBONDABLE ADHESIVE FILM | Henkel AG & Co. KGaA (DE) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025119646-A1 | BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE | HENKEL AG & CO. KGAA (DE) | 2025-06-12 | — | — | WO | disclosed |
| EP-4566808-A1 | BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE | Henkel AG & Co. KGaA (DE) | 2025-06-11 | — | — | EP | disclosed |
| EP-4559671-A1 | METHOD OF SEPARATING BONDED ARTICLES | Henkel AG & Co. KGaA (DE) | 2025-05-28 | — | — | EP | disclosed |
| EP-4559672-A1 | METHOD OF SEPARATING BONDED ARTICLES | Henkel AG & Co. KGaA (DE) | 2025-05-28 | — | — | EP | disclosed |
| US-20250051612-A1 | TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A BIO-RENEWABLE MONOMER | HENKEL AG & CO KGAA (DE) | 2025-02-13 | — | — | US | disclosed |
| US-20250043124-A1 | TWO COMPONENT (2K) ACRYLIC COMPOSITION COMPRISING A THERMOPLASTIC POLYURETHANE | HENKEL AG & CO. KGAA (DE) | 2025-02-06 | — | — | US | disclosed |
| EP-2271685-A1 | POLYURETHANE DISPERSIONS AND COATINGS PRODUCED THEREFROM | Dow Global Technologies Inc. (US) | 2011-01-12 | — | — | EP | disclosed |
| WO-2010126517-A1 | METHOD OF MAKING A DISPERSION OF POLYMER BINDER-ENCAPSULATED SILICA PIGMENTS AND COATED MEDIA INCLUDING SUCH DISPERSION | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2010-11-04 | — | — | WO | disclosed |
| US-20100273939-A1 | POLYURETHANE DISPERSIONS AND COATINGS PRODUCED THEREFROM | DOW GLOBAL TECHNOLOGIES LLC | 2010-10-28 | — | — | US | disclosed |
| WO-2009085587-A1 | POLYURETHANE DISPERSIONS AND COATINGS PRODUCED THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| EP-1888665-A1 | SILANE-MODIFIED UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS AUXILIARY RHEOLOGICAL AGENTS | Construction Research and Technology GmbH (DE) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006131314-A1 | SILANE-MODIFIED UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS AUXILIARY RHEOLOGICAL AGENTS | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2006-12-14 | — | — | WO | disclosed |
| US-6174461-B1 | COMPRISES SOLUTION OF SOLVENT MIXTURE WITH AIR-DRYING FILM FORMING SEALANT COMPONENT SELECTED FROM SILICATES, SILANE MODIFIED SILOXANES, CORROSION INHIBITOR SELECTED FROM AMINE SALTS, AMINO ALCOHOLS, ALKALI GLUCOHEPTONATES, CALCIUM NITRITE | CORTEC CORPORATION | 2001-01-16 | — | — | US | disclosed |
| WO-1998045368-A1 | OLEFIN (CO-)POLYMER COMPOSITIONS AND METHOD OF PRODUCING THE SAME | CHISSO CORPORATION (JP) | 1998-10-15 | — | — | WO | disclosed |
| US-4904516-A | STORAGE STABILITY, BINDERS FOR INSULATION; CATALYTIC CONDENSATION OF ALDEHYDE AND PHENOL | CERTAINTEED CORPORATION, A CORP. OF MD | 1990-02-27 | — | — | US | disclosed |
| US-4588771-A | Stabilized thiofunctional polysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273939-A1 | POLYURETHANE DISPERSIONS AND COATINGS PRODUCED THEREFROM | PUF60, NOTUM, WASF2 | LMNA 1711/4885DNM1 4501/4885MEN1 4143/4885 |
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | EPCAM, CDH1, ITGA4 | LMNA 768/4885DNM1 1403/4885MEN1 2502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.